Clinical Radiology
Volume 62, Issue 4 , Pages 348-352 , April 2007

Radiological and pathological findings of interval cancers in a multi-centre, randomized, controlled trial of mammographic screening in women from age 40–41 years

  • A.J. Evans

      Affiliations

    • Breast Institute, Nottingham City Hospital, Nottingham, UK
    • Corresponding Author InformationGuarantor and correspondent: A. Evans, Breast Institute, Nottingham City Hospital NHS Trust, Hucknall Road, Nottingham NG5 1PB, UK. Tel.: +44 0115 9691689; fax: +44 0115 627 707.
    • ,
  • E. Kutt

      Affiliations

    • Avon Breast Cancer Screening Unit, Central Health Clinic, Tower Hill, Bristol, Avon, UK
    • ,
  • C. Record

      Affiliations

    • Breast Screening Service, Stoke Mandeville Hospital, Aylesbury, UK
    • ,
  • M. Waller

      Affiliations

    • Cancer Screening Evaluation Unit, Institute of Cancer Research, London, UK
    • ,
  • L. Bobrow

      Affiliations

    • Histopathology, Addenbrookes Hospital, Cambridge, UK
    • ,
  • S. Moss

      Affiliations

    • Cancer Screening Evaluation Unit, Institute of Cancer Research, London, UK

Received 4 September 2006 ,Revised 12 October 2006 ,Accepted 24 October 2006.

References 

  1. Taylor R, Page A, Bampton D, et al. Age-specific interval breast cancers in New South Wales and Meta-analysis of studies of women aged 40–49 years. J Med Screen. 2004;11:199–206
  2. Andersson I, Aspergen K, Janzon L, et al. Mammographic screening and mortality from breast cancer: the Malmo Mammographic Screening Trial. BMJ. 1988;297:943–948
  3. Bjurstam N, Bjorneld L, Duffy SW, et al. The Gothenburg Breast Screening Trial. First results on mortality, incidence and mode of detection for women ages 39–49 years at randomization. Cancer. 1997;80:2091–2099
  4. Erbas B, Amos A, Fletcher A, et al. Incidence of invasive breast cancer and ductal carcinoma in situ in a screening programme by age: should older women continue screening?. Cancer Epidemiol Biomarkers Prev. 2004;13:1569–1573
  5. Ugnat AM, Xie L, Morriss J, et al. Survival of women with breast cancer in Ottawa, Canada: variation with age, stage, histology, grade and treatment. Br J Cancer. 2004;90:1138–1143
  6. Sibbering DM, Burrell HC, Evans AJ, et al. Mammographic sensitivity in women under 50 presenting symptomatically with breast cancer. Breast. 1995;4:127–129
  7. De Nunzio MC, Evans AJ, Pinder SE, et al. Correlations between the mammographic features of prevalent round screen detected invasive breast cancer and pathological prognostic factors. Breast. 1997;6:146–149
  8. Warren RML, Young JR, McLean L, et al. Radiology review of the UKCCCR Breast Screening Frequency Trial: potential improvements in sensitivity and lead-time of radiological signs. Clin Radiol. 2003;58:128–132
  9. Evans AJ, Wilson ARM, Burrell HC, et al. Mammographic features of ductal carcinoma in situ (DCIS) present on previous mammography. Clin Radiol. 1999;54:644–646
  10. Moss S, Thomas I, Evans A, et al. Randomised, controlled trial of mammographic screening in women from age 40: results of screening in the first 10 years. Br J Cancer. 2005;92:949–954
  11. Wolfe JN. Breast parenchymal patterns and their changes with age. Radiology. 1976;121:545–552
  12. Mandelson M, Oestreicher N, Porter P, et al. Breast density as a predictor of mammographic detection: comparison of interval screen-detected cancers. J Natl Cancer Inst. 2000;92:1081–1087
  13. Ciatto S, Visioli C, Paci E, et al. Breast density as a determinant of interval cancer at mammographic screening. Br J Cancer. 2004;90:393–396
  14. Rosenberg RD, Hunt WC, Williamson MR, et al. Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183,134 screening mammograms in Albuquerque, New Mexico. Radiology. 1998;209:511–518
  15. Buist DS, Porter PL, Lehman C, et al. Factors contributing to mammography failure in women aged 40–49 years. J Natl Cancer Inst. 2004;96:1432–1440
  16. Vitak B, Olsen K, Manson J, et al. Tumour characteristics and survival in patients with invasive breast cancer classified according to mammographic findings at the latest screening: a comparison of true interval and missed interval cancers. Eur Radiol. 1999;9:460–469
  17. Burrell H, Sibbering D, Wilson A, et al. Screening interval breast cancers: mammographic features and prognosis factors. Radiology. 1996;199:615–620
  18. Amos AF, Kavanagh AM, Cawson J. Radiology Quality Assurance Group of BreastScreen Victoria. Radiological review of interval cancers in an Australian mammographic screening programme. J Med Screen. 2000;7:184–189
  19. De Rijke JM, Schouten LJ, Schreutelkamp JL, et al. A blind review and an informed review of interval breast cancer cases in the Limburg screening programme, The Netherlands. J Med Screen. 2000;7:19–23
  20. Meeson S, Young KC, Wallis MG, et al. Image features of true positive and false negative cancers in screening mammograms. Br J Radiol. 2003;76:13–21
  21. Ferranti C, Coopmans de Yoldi G, Biganzoli E, et al. Relationship between age mammographic features and pathological tumour characterisics in non-palpable breast cancer. Br J Radiol. 2000;73:698–705
  22. Evans AJ, Kutt E, Record C, et al. Radiological findings of screen-detected cancers in a multi-centre randomized, controlled trial of mammographic screening in women from age 40 to 48 years. Clin Radiol. 2006;69:784–788

PII: S0009-9260(06)00410-7

doi: 10.1016/j.crad.2006.10.010

Clinical Radiology
Volume 62, Issue 4 , Pages 348-352 , April 2007

Article Tools